⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for small intestine lymphoma

Every month we try and update this database with for small intestine lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerNCT00274885
Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI)
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaNCT00006039
Lymphoma
Small Intestine...
pegylated inter...
18 Years - Memorial Sloan Kettering Cancer Center
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryNCT00004895
Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Nausea and Vomi...
Ovarian Cancer
Pancreatic Canc...
Peritoneal Cavi...
Small Intestine...
octreotide acet...
18 Years - Northwestern University
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumNCT00005860
Cancer
floxuridine
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681
Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI)
Irinotecan and Capecitabine in Treating Patients With Solid TumorsNCT00003867
Cancer
capecitabine
irinotecan hydr...
18 Years - 120 YearsMontefiore Medical Center
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin LymphomaNCT02281279
B-cell Adult Ac...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Hair...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenström Mac...
rituximab
lenalidomide
romidepsin
laboratory biom...
18 Years - Mayo Clinic
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191
Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI)
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerNCT00397384
Adenocarcinoma ...
Adenocarcinoma ...
Advanced Adult ...
Carcinoma of th...
Gastrointestina...
Metastatic Gast...
Metastatic Squa...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Colon...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Unresectable Ex...
Unresectable Ga...
cetuximab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Irinotecan and Capecitabine in Treating Patients With Solid TumorsNCT00003867
Cancer
capecitabine
irinotecan hydr...
18 Years - 120 YearsMontefiore Medical Center
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin LymphomaNCT01815749
Adult Grade III...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Post-transplant...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Hair...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenström Mac...
autologous CD19...
autologous hema...
laboratory biom...
18 Years - City of Hope Medical Center
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenNCT00016380
Cancer
dexamethasone
ondansetron
quality-of-life...
16 Years - 120 YearsCanadian Cancer Trials Group
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin LymphomaNCT00054639
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenström Mac...
oblimersen sodi...
rituximab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin LymphomaNCT01815749
Adult Grade III...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Post-transplant...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Hair...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenström Mac...
autologous CD19...
autologous hema...
laboratory biom...
18 Years - City of Hope Medical Center
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681
Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI)
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaNCT00006039
Lymphoma
Small Intestine...
pegylated inter...
18 Years - Memorial Sloan Kettering Cancer Center
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryNCT00004895
Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Nausea and Vomi...
Ovarian Cancer
Pancreatic Canc...
Peritoneal Cavi...
Small Intestine...
octreotide acet...
18 Years - Northwestern University
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaNCT00079261
Lymphoma
Small Intestine...
CHOP regimen
cyclophosphamid...
doxorubicin hyd...
gemcitabine hyd...
prednisone
vincristine sul...
18 Years - 70 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasNCT02213913
Adult Grade III...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Small Intestine...
Splenic Margina...
Stage 0 Chronic...
Stage I Adult D...
Stage I Adult D...
Stage I Adult D...
Stage I Adult H...
Stage I Adult I...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Grade 3...
Stage I Mantle ...
Stage I Margina...
Stage I Small L...
Stage II Adult ...
Stage II Chroni...
Stage II Small ...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Testicular Lymp...
Untreated Hairy...
Waldenström Mac...
lenalidomide
etoposide
prednisone
vincristine sul...
doxorubicin hyd...
cyclophosphamid...
rituximab
quality-of-life...
laboratory biom...
18 Years - University of Chicago
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerNCT00005049
Colorectal Canc...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Ovarian Cancer
Peritoneal Cavi...
Small Intestine...
carboplatin
cisplatin
floxuridine
18 Years - NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681
Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI)
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNCT00720135
Anaplastic Larg...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Margi...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenstrom Mac...
DI-Leu16-IL2 im...
rituximab
flow cytometry
immunohistochem...
pharmacological...
laboratory biom...
enzyme-linked i...
reverse transcr...
18 Years - 65 YearsCity of Hope Medical Center
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple MyelomaNCT02037256
Adult Grade III...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Hair...
Refractory Mult...
Small Intestine...
Splenic Margina...
Stage I Adult B...
Stage I Adult D...
Stage I Adult D...
Stage I Adult D...
Stage I Adult I...
Stage I Adult L...
Stage I Grade 1...
Stage I Grade 2...
Stage I Grade 3...
Stage I Mantle ...
Stage I Margina...
Stage I Multipl...
Stage I Small L...
Stage II Multip...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Grade...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Multi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Untreated Hairy...
Waldenström Mac...
bortezomib
filgrastim
autologous hema...
18 Years - 70 YearsBarbara Ann Karmanos Cancer Institute
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerNCT00019773
Carcinoma of th...
Colorectal Canc...
Small Intestine...
capecitabine
oxaliplatin
18 Years - National Cancer Institute (NCI)
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsNCT00253383
Cancer
counseling inte...
educational int...
psychosocial as...
quality-of-life...
18 Years - Dartmouth-Hitchcock Medical Center
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenNCT00016380
Cancer
dexamethasone
ondansetron
quality-of-life...
16 Years - 120 YearsCanadian Cancer Trials Group
PV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerNCT00055705
Cancer
PV701
18 Years - National Cancer Institute (NCI)
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaNCT00079261
Lymphoma
Small Intestine...
CHOP regimen
cyclophosphamid...
doxorubicin hyd...
gemcitabine hyd...
prednisone
vincristine sul...
18 Years - 70 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaNCT00006039
Lymphoma
Small Intestine...
pegylated inter...
18 Years - Memorial Sloan Kettering Cancer Center
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionNCT00004911
Colorectal Canc...
Constipation, I...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Quality of Life
Small Intestine...
bowel obstructi...
quality-of-life...
18 Years - Northwestern University
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionNCT00004910
Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Pancreatic Canc...
Quality of Life
Small Intestine...
bowel obstructi...
quality-of-life...
18 Years - Northwestern University
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerNCT00005049
Colorectal Canc...
Gastric Cancer
Gastrointestina...
Gastrointestina...
Ovarian Cancer
Peritoneal Cavi...
Small Intestine...
carboplatin
cisplatin
floxuridine
18 Years - NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681
Advanced Adult ...
Carcinoma of th...
Estrogen Recept...
Extensive Stage...
Gastrointestina...
HER2-negative B...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Progesterone Re...
Recurrent Adeno...
Recurrent Adult...
Recurrent Anal ...
Recurrent Basal...
Recurrent Borde...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Endom...
Recurrent Esoph...
Recurrent Esthe...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Saliv...
Recurrent Small...
Recurrent Small...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Small Intestine...
Small Intestine...
Small Intestine...
Stage IV Adenoi...
Stage IV Anal C...
Stage IV Basal ...
Stage IV Border...
Stage IV Breast...
Stage IV Colon ...
Stage IV Endome...
Stage IV Esopha...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IV Rectal...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Stage IVA Cervi...
Stage IVB Cervi...
Triple-negative...
Unresectable Ex...
Unresectable Ga...
Unspecified Adu...
Untreated Metas...
7-hydroxystauro...
irinotecan hydr...
diagnostic labo...
18 Years - National Cancer Institute (NCI)
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNCT00720135
Anaplastic Larg...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Margi...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenstrom Mac...
DI-Leu16-IL2 im...
rituximab
flow cytometry
immunohistochem...
pharmacological...
laboratory biom...
enzyme-linked i...
reverse transcr...
18 Years - 65 YearsCity of Hope Medical Center
MDX-010 in Treating Patients With Recurrent or Refractory LymphomaNCT00089076
Adult Grade III...
B-cell Chronic ...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Refractory Hair...
Small Intestine...
Splenic Margina...
Testicular Lymp...
Waldenström Mac...
ipilimumab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: